Biogen | BIIB - Résultat Par Action Eps


Fiscal Calendrier Actuel Consensus Précédent Date
FY2026Q3 Sep/2025 3.83 4.81 Oct/29
FY2026Q2 Jun/2026 3.21 5.47 Jul/29
FY2026Q1 Mar/2026 3.57 3.06 3.02 Apr/29
FY2025Q4 Dec/2025 1.99 1.74 3.44 Feb/06
FY2025Q3 Sep/2025 4.81 3.84 4.08 Oct/30




Eps Changement Date
AbbVie USD 2.65 0.06 2026-03
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
ALKERMES USD -0.4 0.69 2026-03
Amgen USD 5.15 0.14 2026-03
Bayer EUR 2.71 2.09 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Eli Lilly USD 8.55 1.01 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Incyte USD 1.81 0.01 2026-03
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Neurocrine Biosciences USD 1.94 0.06 2026-03
Novartis USD 2.41 0.42 2026-06
Pfizer USD 0.75 0.09 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sanofi EUR 2.17 2.84 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
Teva Pharmaceutical Industries USD 1.57 1.41 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03